BrainsWay Ltd (BWAY)
5.40
-0.02
(-0.37%)
USD |
NASDAQ |
May 16, 16:00
5.42
+0.02
(+0.37%)
After-Hours: 20:00
BrainsWay Max Drawdown (5Y): 88.14% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 88.14% |
March 31, 2024 | 88.14% |
February 29, 2024 | 88.14% |
January 31, 2024 | 88.14% |
December 31, 2023 | 88.14% |
November 30, 2023 | 88.14% |
October 31, 2023 | 88.14% |
September 30, 2023 | 88.14% |
August 31, 2023 | 88.14% |
July 31, 2023 | 88.14% |
June 30, 2023 | 88.14% |
May 31, 2023 | 88.14% |
April 30, 2023 | 87.45% |
March 31, 2023 | 86.64% |
February 28, 2023 | 85.95% |
January 31, 2023 | 85.95% |
December 31, 2022 | 85.95% |
November 30, 2022 | 84.61% |
October 31, 2022 | 71.97% |
September 30, 2022 | 71.32% |
August 31, 2022 | 67.26% |
July 31, 2022 | 63.44% |
June 30, 2022 | 63.44% |
May 31, 2022 | 58.33% |
April 30, 2022 | 57.49% |
Date | Value |
---|---|
March 31, 2022 | 57.49% |
February 28, 2022 | 57.49% |
January 31, 2022 | 57.49% |
December 31, 2021 | 57.49% |
November 30, 2021 | 57.49% |
October 31, 2021 | 57.49% |
September 30, 2021 | 57.49% |
August 31, 2021 | 57.49% |
July 31, 2021 | 57.49% |
June 30, 2021 | 57.49% |
May 31, 2021 | 57.49% |
April 30, 2021 | 57.49% |
March 31, 2021 | 57.49% |
February 28, 2021 | 57.49% |
January 31, 2021 | 57.49% |
December 31, 2020 | 57.49% |
November 30, 2020 | 57.49% |
October 31, 2020 | 57.49% |
September 30, 2020 | 57.49% |
August 31, 2020 | 57.49% |
July 31, 2020 | 57.49% |
June 30, 2020 | 57.49% |
May 31, 2020 | 57.49% |
April 30, 2020 | 57.49% |
March 31, 2020 | 57.49% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
12.52%
Minimum
May 2019
88.14%
Maximum
May 2023
61.95%
Average
57.49%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Compugen Ltd | 97.28% |
Pluri Inc | 96.47% |
BioLine Rx Ltd | 97.41% |
Can Fite Biofarma Ltd | 99.32% |
BiomX Inc | 98.75% |